Eli Lilly and Company (LLY) vs Oracle Corporation (ORCL)
A side-by-side comparison of Eli Lilly and Company and Oracle Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
Different business models: LLY is classified in Healthcare; ORCL is classified in Technology. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
LLY
Eli Lilly and Company
$1,222.61HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
ORCL
Oracle Corporation
$119.99TechnologyDelayed quote: Jul 28, 2026, 3:59 PM EDT
Total return — LLY vs ORCL
growth of $100 · dividends reinvested · last 30yLLY +8631.2%ORCL +3573.7%LLY compounded faster
LLY ORCL
LLY vs ORCL: by the numbers
- •LLY is the larger company ($1.15T vs $345.63B market cap).
- •ORCL trades at the lower trailing earnings multiple (20.57 vs 42.54 P/E), one valuation lens rather than an overall verdict.
- •LLY converts more revenue to profit (34.98% vs 25.37% net margin).
- •LLY grew revenue faster over the past five years (23.17% vs 10.72% CAGR).
- •ORCL pays the higher dividend yield (1.67% vs 0.54%).
Metrics side by side
Valuation
| Metric | LLY | ORCL |
|---|---|---|
| P/E ratio | 42.54 | 20.57 |
| Forward P/E | 34.10 | 16.01 |
| P/S ratio | 14.85 | 5.19 |
| P/B ratio | 34.39 | 8.22 |
| PEG ratio | 0.49 | 1.26 |
| EV / EBITDA | 31.98 | 16.52 |
| FCF yield | 1.27% | N/A |
Profitability
| Metric | LLY | ORCL |
|---|---|---|
| Gross margin | 83.51% | 65.81% |
| Operating margin | 45.87% | 30.85% |
| Net margin | 34.98% | 25.37% |
| ROE | 81.01% | 40.20% |
| ROIC | 30.20% | 7.99% |
Dividends
| Metric | LLY | ORCL |
|---|---|---|
| Dividend yield | 0.54% | 1.67% |
| Payout ratio | 28.09% | 33.67% |
Growth (annualized)
| Metric | LLY | ORCL |
|---|---|---|
| Revenue CAGR (5Y) | 23.17% | 10.72% |
| EPS CAGR (5Y) | 28.88% | 4.93% |
| FCF CAGR (5Y) | 19.54% | -13.18% |
| Total return CAGR (5Y) | 38.81% | 7.88% |
Frequently asked
- Which has the lower trailing P/E, LLY or ORCL?
- ORCL has the lower trailing P/E: LLY trades at 42.54 and ORCL at 20.57. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, LLY or ORCL?
- Over the past five years, LLY grew revenue faster — LLY at a 23.17% CAGR versus ORCL at 10.72%.
- Does LLY or ORCL pay a bigger dividend?
- LLY yields 0.54% and ORCL yields 1.67% based on trailing dividends and the latest price.
- Is LLY or ORCL more profitable?
- LLY runs the higher net margin — LLY at 34.98% versus ORCL at 25.37%.
- How have LLY and ORCL total returns compared?
- Over the past 10 years, LLY delivered 32.66% and ORCL delivered 13.02% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Eli Lilly and P/E ratioOracle P/E ratioEli Lilly and dividend yieldOracle dividend yieldEli Lilly and ROEOracle ROEEli Lilly and operating marginOracle operating marginEli Lilly and revenue growthOracle revenue growthEli Lilly and free cash flowOracle free cash flow
Eli Lilly and & Oracle appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.